Pathstone Holdings’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$541K Sell
3,939
-4,170
-51% -$573K ﹤0.01% 1687
2025
Q1
$1.46M Buy
8,109
+3,857
+91% +$695K 0.01% 1153
2024
Q4
$666K Sell
4,252
-795
-16% -$125K ﹤0.01% 1595
2024
Q3
$919K Buy
+5,047
New +$919K ﹤0.01% 1411